检验医学 ›› 2023, Vol. 38 ›› Issue (10): 997-1002.DOI: 10.3969/j.issn.1673-8640.2023.10.017
收稿日期:
2022-05-23
修回日期:
2022-11-20
出版日期:
2023-10-30
发布日期:
2023-12-18
通讯作者:
卢建华,E-mail:lujianhua@163.com。
作者简介:
鲁启源,男,1998年生,硕士,主要从事骨与关节疾病临床诊疗工作。
Received:
2022-05-23
Revised:
2022-11-20
Online:
2023-10-30
Published:
2023-12-18
摘要:
人工关节假体周围感染(PJI)需要及时、准确的诊断,但目前的诊断标准并不能识别所有级别的感染。在病史和体格检查明确的情况下,C反应蛋白等传统生物标志物仍然作为诊断假体周围感染的首选指标被广泛使用。然而,随着对假体周围感染研究的深入,新的生物标志物及其相关检测技术不断出现,对假体周围感染的诊断效能不断提高。文章对假体周围感染相关生物标志物及其检测技术的研究进展进行综述。
中图分类号:
鲁启源, 卢建华. 人工关节假体周围感染诊断生物标志物研究进展[J]. 检验医学, 2023, 38(10): 997-1002.
LU Qiyuan, LU Jianhua. Biomarker research progress for the diagnosis of periprosthetic joint infection[J]. Laboratory Medicine, 2023, 38(10): 997-1002.
[1] |
AHMED S S, YAGHMOUR K M, HADDAD F S. The changing face of infection,diagnosis,and management in the United Kingdom[J]. Orthop Clin North Am, 2020, 51(2):141-146.
DOI URL |
[2] |
GOSWAMI K, PARVIZI J, MAXWELL COURTNEY P. Current recommendations for the diagnosis of acute and chronic PJI for hip and knee-cell counts,alpha-defensin,leukocyte esterase,next-generation sequencing[J]. Curr Rev Musculoskelet Med, 2018, 11(3):428-438.
DOI |
[3] |
PARVIZI J, ZMISTOWSKI B, BERBARI E F, et al. New definition for periprosthetic joint infection:from the workgroup of the Musculoskeletal Infection Society[J]. Clin Orthop Relat Res, 2011, 469(11):2992-2994.
DOI URL |
[4] |
PARVIZI J, TAN T L, GOSWAMI K, et al. The 2018 definition of periprosthetic hip and knee infection:an evidence-based and validated criteria[J]. J Arthroplasty, 2018, 33(5):1309-1314.
DOI URL |
[5] | 中华医学会骨科学分会关节外科学组《中国PJI诊断和治疗指南》编写委员会. 中国人工关节感染诊断与治疗指南[J]. 中华外科杂志, 2021, 59(6):430-442. |
[6] |
PAZIUK T, RONDON A J, GOSWAMI K, et al. A novel adjunct indicator of periprosthetic joint infection:platelet count and mean platelet volume[J]. J Arthroplasty, 2020, 35(3):836-839.
DOI URL |
[7] |
SALEH A, GEORGE J, FAOUR M, et al. Serum biomarkers in periprosthetic joint infections[J]. Bone Joint Res, 2018, 7(1):85-93.
DOI PMID |
[8] |
AKGÜN D, MÜLKER M, PERKA C, et al. The serum level of C-reactive protein alone cannot be used for the diagnosis of prosthetic joint infections,especially in those caused by organisms of low virulence[J]. Bone Joint J, 2018, 100-B(11):1482-1486.
DOI URL |
[9] |
SIGMUND I K, HOLINKA J, STAATS K, et al. Inferior performance of established and novel serum inflammatory markers in diagnosing periprosthetic joint infections[J]. Int Orthop, 2021, 45(4):837-846.
DOI PMID |
[10] |
CARLI A V, ABDELBARY H, AHMADZAI N, et al. Diagnostic accuracy of serum,synovial,and tissue testing for chronic periprosthetic joint infection after hip and knee replacements:asystematic review[J]. J Bone Joint Surg Am, 2019, 101(7):635-649.
DOI URL |
[11] |
RONDE-OUSTAU C, DIESINGER Y, JENNY J Y, et al. Diagnostic accuracy of intra-articular C-reactive protein assay in periprosthetic knee joint infection-a preliminary study[J]. Orthop Traumatol Surg Res, 2014, 100(2):217-220.
DOI URL |
[12] |
WANG H, QIN L, WANG J, et al. Combined serum and synovial C-reactive protein tests:a valuable adjunct to the diagnosis of chronic prosthetic joint infection[J]. BMC Musculoskelet Disord, 2021, 22(1):670.
DOI |
[13] |
NANA A, NELSON S B, MCLAREN A, et al. What's new in musculoskeletal infection:update on biofilms[J]. J Bone Joint Surg Am, 2016, 98(14):1226-1234.
DOI URL |
[14] |
ABDELBARY H, CHENG W, AHMADZAI N, et al. Combination tests in the diagnosis of chronic periprosthetic joint infection:systematic review and development of a stepwise clinical decision-making tool[J]. J Bone Joint Surg Am, 2020, 102(Suppl 2):114-124.
DOI URL |
[15] |
LAZARIDES A L, VOVOS T J, REDDY G B, et al. Traditional laboratory markers hold low diagnostic utility for immunosuppressed patients with periprosthetic joint infections[J]. J Arthroplasty, 2019, 34(7):1441-1445.
DOI PMID |
[16] |
HU B, YANG Y, ZHAO C, et al. Accuracy of neutrophil CD64 expression in diagnosing infection in patients with autoimmune diseases:a meta-analysis[J]. Clin Rheumatol, 2019, 38(5):1319-1328.
DOI |
[17] |
SALEH A, GEORGE J, FAOUR M, et al. Serum biomarkers in periprosthetic joint infections[J]. Bone Joint Res, 2018, 7(1):85-93.
DOI PMID |
[18] |
QIN L, HU N, LI X, et al. Evaluation of synovial fluid neutrophil CD64 index as a screening biomarker of prosthetic joint infection[J]. Bone Joint J, 2020, 102-B(4):463-469.
DOI PMID |
[19] |
JUBEL J M, RANDAU T M, BECKER-GOTOT J, et al. sCD28,sCD80,sCTLA-4,and sBTLA are promising markers in diagnostic and therapeutic approaches for aseptic loosening and periprosthetic joint infection[J]. Front Immunol, 2021, 12:687065.
DOI URL |
[20] |
SUEN K, KEEKA M, AILABOUNI R, et al. Synovasure 'quick test' is not as accurate as the laboratory-based α-defensin immunoassay:a systematic review and metaanalysis[J]. Bone Joint J, 2018, 100-B(1):66-72.
DOI URL |
[21] |
SIGMUND I K, HOLINKA J, GAMPER J, et al. Qualitative α-defensin test(synovasure) for the diagnosis of periprosthetic infection in revision total joint arthroplasty[J]. Bone Joint J, 2017, 99-B(1):66-72.
DOI URL |
[22] |
RENZ N, YERMAK K, PERKA C, et al. Alpha defensin lateral flow test for diagnosis of periprosthetic joint infection:not a screening but a confirmatory test[J]. J Bone Joint Surg Am, 2018, 100(9):742-750.
DOI URL |
[23] |
BALATO G, DE MATTEO V, ASCIONE T, et al. Laboratory-based versus qualitative assessment of α-defensin in periprosthetic hip and knee infections:a systematic review and meta-analysis[J]. Arch Orthop Trauma Surg, 2020, 140(3):293-301.
DOI |
[24] | DEIRMENGIAN C, FEELEY S, KAZARIAN G S, et al. Synovial fluid aspirates diluted with saline or blood reduce the sensitivity of traditional and contemporary synovial fluid biomarkers[J]. Clin OrthopRelat Res, 2020, 478(8):1805-1813. |
[25] | BONANZINGA T, ZAHAR A, DÜTSCH, et al. How reliable is the alpha-defensin immunoassay test for diagnosing periprosthetic joint infection? A prospective study[J]. Clin OrthopRelat Res, 2017, 475(2):408-415. |
[26] |
STONE W Z, GRAY C F, PARVATANENI H K, et al. Clinical evaluation of synovial alpha defensin and synovial C-reactive protein in the diagnosis of periprosthetic joint infection[J]. J Bone Joint Surg Am, 2018, 100(14):1184-1190.
DOI PMID |
[27] | SIGMUND I K, YERMAK K, PERKA C, et al. Is the enzyme-linked immunosorbent assay more accurate than the lateral flow alpha defensin test for diagnosing periprosthetic joint infection[J]. Clin OrthopRelat Res, 2018, 476(8):1645-1654. |
[28] |
KLEISS S, JANDL N M, NOVO DE OLIVEIRA A, et al. Diagnostic accuracy of alpha-defensin enzyme-linked immunosorbent assay in the clinical evaluation of painful hip and knee arthroplasty with possible prosthetic joint infection:a prospective study of 202 cases[J]. Bone Joint J, 2019, 101-B(8):970-977.
DOI URL |
[29] |
IORIO R, VIGLIETTA E, MAZZA D, et al. Accuracy and cost-effectivenss of a novel method for alpha defensins measurement in the diagnosis of periprosthetic joint infections[J]. J Arthroplasty, 2021, 36(9):3275-3281.
DOI URL |
[30] |
KELLY M P, DARRITH B, HANNON C P, et al. Synovial fluid alpha-defensin is an adjunctive tool in the equivocal diagnosis of periprosthetic joint infection[J]. J Arthroplasty, 2018, 33(11):3537-3540.
DOI PMID |
[31] |
AMANATULLAH D F, CHENG R Z, HUDDLESTON LII J I, et al. The routine use of synovial alpha-defensin is not necessary[J]. Bone Joint J, 2020, 102-B(5):593-599.
DOI PMID |
[32] |
COOPER K B, SIEGEL E R, STAMBOUGH J B, et al. The alpha-defensin prosthetic joint infection test has poor validity for native knee joint infection[J]. J Arthroplasty, 2021, 36(8):2957-2961.
DOI URL |
[33] | MELICHERÍK P, KLAPKOVÁ E, KOTAŠKA K, et al. High-performance liquid chromatography as a novel method for the determination of α-defensins in synovial fluid for diagnosis of orthopedic infections[J]. Diagnostics(Basel), 2020, 10(1):33. |
[34] |
ZAGRA L, VILLA F, CAPPELLETTI L, et al. Can leucocyte esterase replace frozen sections in the intraoperative diagnosis of prosthetic hip infection[J]. Bone Joint J, 2019, 101-B(4):372-377.
DOI URL |
[35] |
YERMAK K, KARBYSHEVA S, PERKA C, et al. Performance of synovial fluid D-lactate for the diagnosis of periprosthetic joint infection:a prospective observational study[J]. J Infect, 2019, 79(2):123-129.
DOI URL |
[36] |
MAJORA I, JAGADALE V S. Serum interleukin 6 could be a valuable initial diagnostic tool in prosthetic knee joint infections[J]. Eur J Orthop Surg Traumatol, 2019, 29(8):1781-1788.
DOI PMID |
[37] |
FILLEROVA R, GALLO J, RADVANSKY M, et al. Excellent diagnostic characteristics for ultrafast gene profiling of DEFA1-IL1B-LTF in detection of prosthetic joint infections[J]. J Clin Microbiol, 2017, 55(9):2686-2697.
DOI URL |
[38] |
SOUSA R, SERRANO P, GOMES DIAS J, et al. Improving the accuracy of synovial fluid analysis in the diagnosis of prosthetic joint infection with simple and inexpensive biomarkers:C-reactive protein and adenosine deaminase[J]. Bone Joint J, 2017, 99-B(3):351-357.
DOI URL |
[39] |
OMAR M, KLAWONN F, BRAMD S, et al. Transcriptome-wide high-density microarray analysis reveals differential gene transcription in periprosthetic tissue from hips with chronic periprosthetic joint infection vs aseptic loosening[J]. J Arthroplasty, 2017, 32(1):234-240.
DOI PMID |
[40] |
WORTHINGTON T, DUNLOP D, CASEY A, et al. Serum procalcitonin,interleukin-6,soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision[J]. Br J Biomed Sci, 2010, 67(2):71-76.
DOI URL |
[1] | 孙泽朋, 王洪彬, 王建东, 宋德伟, 肖鹏. 心肌损伤多肽和蛋白类标志物方法学分析和进展[J]. 检验医学, 2023, 38(8): 784-789. |
[2] | 张敏, 王彬宇, 迟伟群, 刘禹. 外泌体非编码RNA作为疾病诊断生物标志物的研究进展[J]. 检验医学, 2023, 38(6): 594-598. |
[3] | 刘庆阳, 袁建明, 夏进军, 姜风英, 王秋波, 王晓明. 基于GEO数据库和临床样本验证CXCL9作为类风湿关节炎生物标志物的研究[J]. 检验医学, 2023, 38(12): 1121-1129. |
[4] | 周福荣, 李龑杼, 刘勇敢. lncRNA SNP在结直肠癌易感性预测和预后评估中的应用[J]. 检验医学, 2023, 38(12): 1206-1210. |
[5] | 陈雪薇, 李一荣. 基于GEO数据库筛选代谢综合征潜在生物标志物[J]. 检验医学, 2023, 38(1): 32-38. |
[6] | 吴亚婷, 李卓林, 雷艳, 贾如雪, 张胜行, 王水良. 尿液中miRNA作为常见恶性肿瘤生物标志物研究进展[J]. 检验医学, 2023, 38(1): 94-99. |
[7] | 王芮, 李朝燕, 赵爱光. 循环肿瘤DNA检测在胃癌诊疗中的应用现状[J]. 检验医学, 2022, 37(9): 877-881. |
[8] | 邬燕倩, 俞翀, 沈鹭, 郑浩然, 洪叶挺. 体液piRNA作为疾病潜在生物标志物的研究进展[J]. 检验医学, 2022, 37(8): 782-786. |
[9] | 冯雪晴, 居漪, 李卿, 金中淦. 电化学适配体传感器检测生物标志物研究进展[J]. 检验医学, 2022, 37(5): 477-482. |
[10] | 高东田, 刘利华, 申爱华, 孙寅. 侵袭性肺曲霉菌感染实验诊断新进展[J]. 检验医学, 2021, 36(4): 453-461. |
[11] | 张万乾, 王想福, 任有亮, 郑卉卉. 肝素结合蛋白在感染性疾病中的应用研究进展[J]. 检验医学, 2021, 36(11): 1186-1189. |
[12] | 杜晶辉, 李莎, 刘旭. 新型冠状病毒肺炎诊断的相关实验室检测技术应用[J]. 检验医学, 2020, 35(8): 843-848. |
[13] | 王茜青, 洪娟, 杜超, 褚庆华. 血清组织蛋白酶D检测在非酒精性脂肪性肝病中的临床意义[J]. 检验医学, 2020, 35(6): 578-582. |
[14] | 马英博 综述, 曹文俊 审校. 中性粒细胞/淋巴细胞比值在眼部疾病中的研究进展[J]. 检验医学, 2020, 35(5): 501-505. |
[15] | 刘艳, 龙吟, 潘伟杰, 张通, 翁文浩, 俞莹. 粪便具核梭杆菌与clbA+大肠埃希菌DNA检测在结直肠癌诊断中的价值[J]. 检验医学, 2020, 35(4): 314-317. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||